2-methoxyestradiol has been researched along with Mouth Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Holpuch, A; Koutras, G; Lang, J; Mallery, SR; Nieto, K; Pei, P; Santiago, B; Schwendeman, SP; Spinney, R; Tong, M; Wang, D | 1 |
| Matsui, H; Matsushita, M; Takata, H; Tomizawa, K | 1 |
2 other study(ies) available for 2-methoxyestradiol and Mouth Neoplasms
| Article | Year |
|---|---|
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
Topics: 2-Methoxyestradiol; Animals; Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Estradiol; Fenretinide; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Phenotype; Phosphorylation; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity.
Topics: 2-Methoxyestradiol; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Membrane; Drug Therapy, Combination; Estradiol; Humans; Mouth Neoplasms; NF-kappa B; Peptides; Recombinant Fusion Proteins; Transcription, Genetic; Tumor Suppressor Protein p53 | 2004 |